1. Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia

   • Mohamed Elmeliegy
   • Jason Den Haese
   • William J. Jusko

   Original Article 03 August 2020 Pages: 325 - 337

   

2. Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects

   • Yun Kuang
   • Hui-ling Song
   • Jie Huang

   Original Article Open access 05 August 2020 Pages: 339 - 346

   

3. Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

   • Rong Shi
   • Tong Lu
   • Dan Lu

   Original Article Open access 08 August 2020 Pages: 347 - 359

   

4. miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway

   • Marianna Lucafò
   • Daria Sicari
   • Gabriele Stocco

   Original Article Open access 10 August 2020 Pages: 361 - 374

   

5. Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity

   • Bryan J. Neth
   • Michael W. Ruff
   • Daniel E. Maddox

   Original Article 10 August 2020 Pages: 375 - 382

   

6. Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab

   • Michio Kimura
   • Eiseki Usami
   • Tomoaki Yoshimura

   Original Article 13 August 2020 Pages: 383 - 391

   

7. Aripiprazole prevents from development of vincristine-induced neuropathic nociception by limiting neural NOS overexpression and NF-kB hyperactivation

   • Mina Khalilzadeh
   • Fereshteh Hassanzadeh
   • Hamed Shafaroodi

   Original Article 14 August 2020 Pages: 393 - 404

   

8. Novel biomimetic dual-mode nanodroplets as ultrasound contrast agents with potential ability of precise detection and photothermal ablation of tumors

   • Yuan Liang
   • Hengli Yang
   • Yunyou Duan

   Original Article 14 August 2020 Pages: 405 - 418

   

9. Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines

   • Lalit Birari
   • Shivani Wagh
   • Chandragouda R. Patil

   Original Article 18 August 2020 Pages: 419 - 426

   

10. Neutropenia is an indicator of outcomes in metastatic colorectal cancer patients treated with FTD/TPI plus bevacizumab: a retrospective study

    • Yohei Nose
    • Yoshinori Kagawa
    • Kohei Murata

    Original Article 20 August 2020 Pages: 427 - 433

    

11. Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach

    • Eduard Schmulenson
    • Linda Krolop
    • Ulrich Jaehde

    Original Article Open access 27 August 2020 Pages: 435 - 444

    

12. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis

    • A. Laura Nijstad
    • Natasha K. A. van Eijkelenburg
    • Alwin D. R. Huitema

    Short Communication Open access 20 August 2020 Pages: 445 - 449